2 for 1 sale You pick the included one Any vial, any size. NO CODE, NO LIMITS.

Need help? Call Or Text us, and a team member will be happy to assist you. +1 (855) 322-2214

Tesamorelin

Total Price $663.08
Discounted Price $464.15
Vials 5 vials
You Save
$198.93 30% OFF
Only $92.83 per vial Final price per vial after savings
On Sale!
Tesamorelin – Licensed Peptides
Tesamorelin 20mg V260908 14 Licensed Peptides Report 004 1
Tesamorelin 20mg V260908 14 Licensed Peptides Report 004 2
Tesamorelin 20mg V260908 14 Licensed Peptides Report 004 3
Tesamorelin 10mg (10 vials) – lab report
Tesamorelin 10mg (10 vials) – lab report
Tesamorelin – lab report
Tesamorelin – lab report
Tesamorelin – Licensed Peptides
Tesamorelin 20mg V260908 14 Licensed Peptides Report 004 1
Tesamorelin 20mg V260908 14 Licensed Peptides Report 004 2
Tesamorelin 20mg V260908 14 Licensed Peptides Report 004 3
Tesamorelin 10mg (10 vials) – lab report
Tesamorelin 10mg (10 vials) – lab report
Tesamorelin – lab report
Tesamorelin – lab report
⚠ Popular Peptides ⚠ Research Peptides
Retail Price $597.54
Your Price $597.54 Per vial: $42.58
You Save $597.54 33% OFF
Select Strength (mg)
99% HPLC Purity
Select Vials
Bulk pricing applied
📈 Upgrade to 10 vials and save an extra vs. buying 5 — nearly 3 vials included.
Your included vial Included · 2 for 1
Tesamorelin
Same as above
Included
  • 99%+ HPLC Purity — Independently verified by accredited US laboratory
  • Endotoxin-Screened — LAL tested, LPS-free, endotoxin report available
  • GMP-Certified Manufacturing — USA facility, ISO 9001:2015
  • Lyophilized for Stability — Shipped cold-packed, intact for reconstitution
Molecular Weight
Third Party Tested
APPLICATION
For Research Use only
Form
Lyophilized Powder
Storage
-20°C Long Term
Purity (HPLC)
99%+ Third Party Verified
Manufacture
USA / GMP

Tesamorelin

Total Price $663.08
Discounted Price $464.15
Vials 5 vials
You Save
$198.93 30% OFF
Only $92.83 per vial Final price per vial after savings
⚠ Popular Peptides ⚠ Research Peptides
Select Strength (mg)
99% HPLC Purity
Select Vials
Bulk pricing applied
📈 Upgrade to 10 vials and save an extra vs. buying 5 — nearly 3 vials included.
Your included vial Included · 2 for 1
Tesamorelin
Same as above
Included
  • 99%+ HPLC Purity — Independently verified by accredited US laboratory
  • Endotoxin-Screened — LAL tested, LPS-free, endotoxin report available
  • GMP-Certified Manufacturing — USA facility, ISO 9001:2015
  • Lyophilized for Stability — Shipped cold-packed, intact for reconstitution
Molecular Weight
Third Party Tested
APPLICATION
For Research Use only
Form
Lyophilized Powder
Storage
-20°C Long Term
Purity (HPLC)
99%+ Third Party Verified
Manufacture
USA / GMP
Reagent documentation

Scientific description

Structure, physicochemical data, analytical verification and safety documentation for Tesamorelin. Supplied for in-vitro laboratory research only.

Reagent overview

Reagent
Tesamorelin
Composition
10 mg, 20 mg vial sizes: Tesamorelin
Form
Lyophilised powder, sealed vial
Chromatographic purity, current lot
99.06%
CAS
218949-48-5
Lot on file
V260908-14Released 9/25/2026
Testing laboratory
Vanguard Laboratory, ISO/IEC 17025:2017, A2LA #6377.01.01
Download COA (PDF) Verify with Vanguard Laboratory Lot record in the Testing Library

Molecular structure

Two-dimensional structures generated with RDKit and drawn in the site palette. Tap a drawing to enlarge it. Below each drawing, the residue chain in one-letter code with the three-letter name and position; colours mark the side-chain class, a dashed outline marks a D-residue or a non-proteinogenic residue (lower-case letters are D-residues).

Acidic (Asp, Glu)Basic (Lys, Arg, His)Polar uncharged (Ser, Thr, Asn, Gln, Cys, Tyr)Hydrophobic (Ala, Val, Leu, Ile, Met, Phe, Trp)Gly / ProD- or non-proteinogenic residue

Tesamorelin N-acylated 44-residue peptide amide

2D structure drawing of TesamorelinTap to enlarge

2D depiction, C221H366N72O67S, generated from the PubChem connection table, CID 16137828.

HexYTyr1AAla2DAsp3AAla4IIle5FPhe6TThr7NAsn8SSer9YTyr10RArg11KLys12VVal13LLeu14GGly15QGln16LLeu17SSer18AAla19RArg20KLys21LLeu22LLeu23QGln24DAsp25IIle26MMet27SSer28RArg29QGln30QGln31GGly32EGlu33SSer34NAsn35QGln36EGlu37RArg38GGly39AAla40RArg41AAla42RArg43LLeu44NH2

trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 (terminal groups: N-terminal trans-3-hexenoyl, C-terminal amide)

Physicochemical data

Formula, masses and identifiers from PubChem where a record exists, checked against an independent RDKit calculation and, for peptides, against the residue sequence. Theoretical pI, net charge at pH 7.4, GRAVY and the 280 nm extinction coefficient are calculated with Biopython ProtParam on the residue chain (Bjellqvist pK set; Kyte-Doolittle; Gill and von Hippel) and are marked "calculated"; they are not given where the chain contains non-proteinogenic residues.

Tesamorelin

Molecular formula
C221H366N72O67S
Average molecular weight
5135.9 g/mol
Monoisotopic mass
5132.717 Da
CAS number
218949-48-5
Sequence length
44 residues, N-terminal trans-3-hexenoyl, C-terminal amide
Theoretical pI (calculated)
10.40 (free-terminus model)
Net charge at pH 7.4 (calculated)
+3.6
GRAVY hydropathy (calculated)
-0.798
Extinction coefficient, 280 nm (calculated)
2980 M-1 cm-1
PubChem CID
16137828
InChIKey
QBEPNUQJQWDYKU-BMGKTWPMSA-N
Peptide class
44-residue GHRH sequence with an N-terminal trans-3-hexenoyl group and a C-terminal amide
Appearance
White to off-white lyophilised powder
Solubility
Soluble in water (supplier specification); quantitative solubility not determined
Storage and handling
Store at -20 °C, desiccated and protected from light. The sealed powder tolerates short periods at ambient temperature during shipping.
Shelf life
Refer to the lot Certificate of Analysis; re-test date assigned per lot

Analytical verification, lot V260908-14

Tests reported for the current lot on file by Vanguard Laboratory, ISO/IEC 17025:2017, A2LA #6377.01.01 (released 9/25/2026): reversed-phase HPLC with UV detection (chromatographic purity by peak area, content against the label claim); LAL bacterial endotoxin; ICP-MS heavy metals; GC-MS residual solvents. Only the tests listed below are part of this lot's report.

HPLC-UV chromatogram from the Certificate of Analysis, lot V260908-14Tap to enlarge

HPLC-UV chromatogram, full trace, from page 1 of the lot Certificate of Analysis (diode-array detector, 214 nm).

TestMethodResult
Chromatographic purityHPLC-UV/VIS99.06%
Content (label claim 20 mg)HPLC-UV/VIS21.87 mg
Bacterial endotoxinLAL<5.00 EU/mg (LAL, USP <85>)
Heavy metalsICP-MSArsenic ND (LOQ 0.01 ppm), Cadmium ND (LOQ 0.01 ppm), Lead ND (LOQ 0.01 ppm), Mercury ND (LOQ 0.005 ppm)
Residual solvents and TFAGC-MS, ion chromatographyAll 16 screened residual solvents not detected (GC-MS); TFA not detected (<0.10%, ion chromatography)
Purity reports Endotoxin reports Residual solvent reports Manufacturing process

Safety Data Sheet (SDS)

GHS-format safety data sheet, 16 sections. Revision 2026-11-04, version 1.0. "No data available" is stated wherever no measured data exist for the substance.

Download SDS (PDF)Tesamorelin, CAS 218949-48-5
1.Identification
Product identifier
Tesamorelin
CAS number
218949-48-5
Product form
Lyophilised peptide, supplied by Licensed Peptides in sealed research packaging; the format of each product (vial, blend component, encapsulated research formulation or atomized solution) is stated on its product page.
Recommended use
Laboratory research reagent for in-vitro use by qualified researchers
Restrictions on use
Not for human or veterinary use. Not a drug, food, cosmetic or household product.
Supplier
Licensed Peptides, Inc., 1489 W Palmetto Park Rd, Boca Raton, FL 33486, USA
Supplier contact
service@licensedpeptides.com, +1 (855) 322-2214 (Mon to Fri, 8:30 AM to 6:30 PM ET)
Emergency telephone
+1 (855) 322-2214 (Mon to Fri, 8:30 AM to 6:30 PM ET). For a medical emergency contact local emergency services or a poison control centre.
2.Hazard identification
GHS classification
Not classified under GHS (Rev. 9) on the basis of the data available for this substance.
Signal word
None
Hazard statements
None assigned
Precautionary statements
None assigned. Handle as a laboratory chemical of unknown toxicity: avoid dust formation, avoid contact with eyes, skin and clothing, do not swallow.
Other hazards
Fine lyophilised powder may form dust. No data available on other hazards.
3.Composition / information on ingredients
Substance / mixture
Substance (synthetic peptide), may contain counter-ion and residual water from lyophilisation
Chemical name
trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
Sequence (one-letter)
YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL
Sequence (three-letter)
trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
CAS number
218949-48-5
Molecular formula
C221H366N72O67S
Concentration
Content as stated on the lot Certificate of Analysis (see /lab-reports/).
Impurities contributing to classification
None known
4.First-aid measures
General advice
Show this safety data sheet to the attending physician. Remove contaminated clothing.
If inhaled
Move the person to fresh air. If breathing is difficult, obtain medical attention.
In case of skin contact
Wash with plenty of soap and water. Obtain medical attention if irritation develops or persists.
In case of eye contact
Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. Obtain medical attention if irritation persists.
If swallowed
Rinse mouth with water. Do not induce vomiting. Obtain medical attention.
Most important effects, acute and delayed
No data available.
Indication of immediate medical attention
No data available. Care at the discretion of the attending physician.
5.Fire-fighting measures
Suitable extinguishing media
Water spray, dry chemical, carbon dioxide or alcohol-resistant foam, chosen for the surrounding fire.
Unsuitable extinguishing media
None known.
Specific hazards
Organic powder; combustion may release carbon oxides, nitrogen oxides and sulfur oxides.
Advice for fire-fighters
Wear self-contained breathing apparatus and full fire-fighting gear.
6.Accidental release measures
Personal precautions
Avoid dust formation. Wear gloves, eye protection and a laboratory coat. Ensure adequate ventilation.
Environmental precautions
Do not let the substance enter drains. Quantities supplied are milligram scale.
Containment and clean-up
Sweep up or wipe with a damp cloth without creating dust, place in a closed container for disposal, then clean the area with water.
7.Handling and storage
Precautions for safe handling
Handle in a laboratory setting by trained personnel. Avoid dust formation and contact with skin and eyes. Wash hands after handling. Keep the vial closed when not in use.
Conditions for safe storage
Store lyophilised at -20 °C in the original sealed vial, desiccated and protected from light. Keep away from strong oxidising agents. Short periods at ambient temperature during shipping are tolerated by the lyophilised powder.
Specific end use
Laboratory research reagent only.
8.Exposure controls / personal protection
Occupational exposure limits
None established for this substance.
Engineering controls
Handle the powder in a fume hood or ventilated enclosure. Eyewash station and safety shower should be available.
Eye / face protection
Safety glasses with side shields or chemical goggles (EN 166 or ANSI Z87.1).
Skin protection
Nitrile gloves inspected before use; laboratory coat.
Respiratory protection
Not normally required when handled in a fume hood. For dust-forming operations outside a hood use a particulate respirator (N95 or P2 type).
Hygiene measures
Do not eat, drink or smoke in the laboratory. Wash hands after handling.
9.Physical and chemical properties
Appearance
White to off-white lyophilised powder
Odour
Odourless
Molecular formula
C221H366N72O67S
Molecular weight (average)
5135.9 g/mol
Monoisotopic mass
5132.717 Da
Solubility
Soluble in water (supplier specification). Quantitative solubility: no data available.
pH, melting point, boiling point, flash point, vapour pressure, density, partition coefficient, auto-ignition temperature, decomposition temperature, viscosity
No data available
Flammability
No data available (organic powder, not expected to be readily flammable)
10.Stability and reactivity
Reactivity
No data available.
Chemical stability
Stable under the recommended storage conditions (lyophilised, -20 °C, desiccated, protected from light).
Possibility of hazardous reactions
None known.
Conditions to avoid
Moisture, prolonged exposure to light and elevated temperature; repeated freeze-thaw of solutions.
Incompatible materials
Strong oxidising agents, strong acids and bases.
Hazardous decomposition products
None known under normal storage. Combustion: carbon oxides and nitrogen oxides.
11.Toxicological information
Acute toxicity
No data available for this substance (all exposure routes).
Skin corrosion / irritation
No data available.
Serious eye damage / irritation
No data available.
Respiratory or skin sensitisation
No data available.
Germ cell mutagenicity
No data available.
Carcinogenicity
No data available. Not listed by IARC, NTP or OSHA.
Reproductive toxicity
No data available.
Specific target organ toxicity (single and repeated exposure)
No data available.
Aspiration hazard
No data available.
Additional information
This safety data sheet does not describe biological activity. The substance has not been evaluated for any use other than in-vitro laboratory research.
12.Ecological information
Ecotoxicity
No data available.
Persistence and degradability
No data available. As a peptide it is expected to be hydrolysed by environmental proteases.
Bioaccumulative potential
No data available.
Mobility in soil
No data available.
Other adverse effects
No data available.
13.Disposal considerations
Waste from residues
Dispose of as laboratory chemical waste through a licensed waste disposal contractor in accordance with local, state and federal regulations. Do not discharge to drains.
Contaminated packaging
Dispose of as unused product. Rinsed glass vials may be recycled where local rules allow.
14.Transport information
UN number
Not assigned
UN proper shipping name
Not regulated as a dangerous good
Transport hazard class
Not applicable (DOT, IATA, IMDG)
Packing group
Not applicable
Environmental hazards
Not classified as a marine pollutant
Special precautions
Ship cold-packed; the lyophilised powder tolerates short periods at ambient temperature.
15.Regulatory information
United States (FDA)
This substance is not approved by the US Food and Drug Administration as a drug, food, dietary supplement or cosmetic. It is supplied for in-vitro laboratory research only and is not for human or veterinary use.
OSHA Hazard Communication Standard (29 CFR 1910.1200)
Not classified as hazardous on the basis of available data.
TSCA (US)
Not evaluated. Supplied in research quantities only.
SARA 302 / 313, California Proposition 65
Not listed.
Other
Purchaser must be 21 years of age or older and a qualified researcher. The product may not be used in or on humans or animals.
16.Other information
Revision date
2026-11-04
Version
1.0
Prepared by
Licensed Peptides, Inc. (regulatory and quality documentation)
Data sources
PubChem CID 16137828 (formula, average and monoisotopic mass, InChIKey QBEPNUQJQWDYKU-BMGKTWPMSA-N); lot Certificate of Analysis for purity and content; GHS Revision 9 for section structure.
Disclaimer
The information in this safety data sheet is believed to be accurate as of the revision date and is provided for guidance on safe handling, storage and disposal in a laboratory setting. It is not a specification and does not constitute a warranty. The recipient is responsible for determining the suitability of the substance for the intended research application and for compliance with all applicable regulations.
Intended use. This product is not a drug, food, dietary supplement or cosmetic. It is supplied as a lyophilised laboratory reagent for in-vitro research by qualified researchers only and is not for human or veterinary use. The statements on this page have not been evaluated by the US Food and Drug Administration, and the product is not intended to diagnose, treat, cure or prevent any disease. Purchasers must be 21 years of age or older. Licensed Peptides is a chemical supplier, not a pharmacy.
99%+ Purity
99%+ Purity

Guaranteed per batch

HPLC + LAL
HPLC + LAL

Independent lab verified

Endotoxin-Free
Endotoxin-Free

Vanguard Laboratory · ISO/IEC 17025

GMP-Certified
GMP-Certified

USA-manufactured

Same-Day Shipping
Same-Day Shipping

Free FedEx on $200+

Vendor Comparison

Why Researchers Choose Licensed Peptides

Not all peptide vendors hold themselves to the same verification standards.

Verification Standard Licensed Peptides Generic Vendors
HPLC Purity Analysis ✓ 99%+ Every Batch ✗ Often Not Disclosed
Endotoxin Screening (LAL) ✓ Every Product ✗ Industry Exception
GMP-Certified USA Manufacture ✓ ISO 9001:2015 ✗ Often Overseas
COA Published & Downloadable ✓ Every Lot ✗ Inconsistent
Same-Day USA Fulfillment ✓ Before 4PM PST ✗ 3-10 Day Lead Time
Research Questions

Frequently Asked Questions

Tesamorelin is a synthetic GHRH analogue used in laboratory research to study endogenous growth hormone regulation, IGF-1 signaling, and visceral adipose tissue dynamics in experimental systems. It is not approved for general use.

It binds to GHRH receptors in the anterior pituitary and is used in laboratory studies to examine endocrine signaling behavior. This description is provided for research context only and does not imply therapeutic or clinical use.

No. Tesamorelin is studied as a GHRH analogue, while growth hormone is a different hormone. This distinction is relevant to experimental design and does not indicate medical use.

Tesamorelin is not considered an anabolic agent. Any muscle-related findings discussed in the literature are reported within research contexts only and do not constitute claims of human or animal benefit.

Published research may report tolerability observations under defined study conditions. These observations are included for scientific context only and do not indicate approval for human or veterinary use.

Some research models examine insulin-related markers in relation to GH/IGF-1 and visceral adipose tissue pathways. This is research context only and does not imply clinical benefit.

Tesamorelin is studied for its receptor-mediated signaling profile and downstream endocrine response behavior. Timing observations are model-dependent and are included only for research context.

Tesamorelin is studied as a GHRH analogue with specific relevance to GH/IGF-1 signaling and visceral adipose tissue research models. This is descriptive research context only.

An LPS-free peptide indicates that the material has been tested to ensure the absence of lipopolysaccharides, which are bacterial endotoxins that could interfere with experimental outcomes in sensitive research assays.

Being an endotoxin-free peptide means the product meets strict endotoxin limits, supporting accuracy and reliability in laboratory and investigative research where endotoxin contamination could compromise data integrity.

Frequently Paired With

Researchers Also Order

Not all peptide vendors hold themselves to the same verification standards.

Order Today

Research-Grade
Tesamorelin Ships Same Day

99.4% HPLC Verified · Endotoxin-Screened · GMP-Certified ·
Free FedEx 2-Day on $200+

View Full COA

You cannot copy content of this page